Respiratory infections affect people of all ages and backgrounds, and can range from mild to lethal in terms of severity. Though respiratory infections may be caused by a wide variety of pathogens, the symptoms presented tend to overlap, making it difficult to pinpoint the cause of the infection based on symptoms alone. Traditionally, several rounds of testing and follow-ups may be required to accurately identify the causative pathogens. This may delay appropriate treatment and infection control, which could further result in worsening health conditions and rapid disease spread. With advancements in precision diagnostics, respiratory syndromic testing simplifies the traditional testing process and rapidly identifies pathogens present, facilitating timely treatment and better patient outcomes.

Respiratory syndromic testing with Angsana Multiplex Respiratory Panel produces quick and comprehensive results from justone nasal swab. The panel detects and differentiates between 19 viral and 4 bacterial targets to identify causative pathogens, including co-infections when multiple pathogens are present, minimising misdiagnosis and allowing healthcare providers to adopt targeted treatment plans for each patient. It also provides laboratories and healthcare providers with access to cycle threshold values and amplification curves, which can further inform and optimise treatment plans. By delivering detailed results in a timely manner, this test brings greater accuracy and efficiency to respiratory infection diagnosis and treatment, improving patient management and healthcare outcomes.